Joint British Diabetes Society for Inpatient care

The Joint British Diabetes Society for Inpatient Care (JBDS-IP) aims to improve inpatient diabetes care across the UK through the development and use of high-quality, evidence-based guidelines and inpatient care pathways.

Guidelines

• Management of diabetic ketoacidosis in adults (June 2021)

• Management of Hyperglycaemia and Steroid (Glucocorticoid) therapy (Revised May 2021) (PDF, 1.08 MB)

• Assessment of hyperglycaemia in people taking steroids: Algorithm (PDF, 343 KB)

• Self-management of diabetes in hospital (March 2021) (PDF, 1461 KB)

• Guideline for Perioperative Care for People with Diabetes Mellitus Undergoing Elective and Emergency Surgery (March 2021) (PDF, 218 KB)

• Diabetes at the Front Door (March 2020)

• Inpatient Care of the Frail Older Adult with Diabetes (October 2019)

• A good inpatient diabetes service (July 2019)

• Management of glycaemic control in pregnant women with diabetes on obstetric wards and delivery units (August 2017) 

• Management of diabetes in adults and children with psychiatric disorders in inpatient settings (August 2017)

• Management of adults with diabetes on the haemodialysis unit (April 2016)

• Management of adults with diabetes undergoing surgery and elective procedures: improving standards (revised March 2016)

• Discharge planning for adult inpatients with diabetes (October 2015)

• Use of variable rate intravenous insulin infusion (VRIII) in medical inpatients (October 2014)

• Admissions avoidance and diabetes: guidance for Clinical Commissioning Groups and clinical teams (December 2013)

• Hospital management of hypoglycaemia in adults with diabetes mellitus (April 2021)

• Management of the hyperosmolar hyperglycaemic state (HHS) in adults with diabetes (August 2012)

• Glycaemic management during the inpatient enteral feeding of stroke patients with diabetes (August 2012)

• Self-management of diabetes in hospital (March 2012)

• The management of glycaemic control in patients with cancer (May 2021)

The Rowan Hillson Insulin Safety Award

The Rowan Hillson awards aim to promote excellence in insulin safety. Each year the awards focus on a specific topic.

• 2016 joint winner: Best joint pharmacy and diabetes team initiative to improve insulin and prescribing safety in hospital, A pharmacist led intiative to support insulin self administration, Sheffield Teaching Hospital NHS Foundation Trust (PDF, 261KB)

• 2016 joint winner: Best joint pharmacy and diabetes team initiative to improve insulin and prescribing safety in hospital, Derby Diabetes Inpatient Improvement Projects ( DIPs), Royal Derby Teaching Hospital NHS Foundation Trust (PDF, 407KB)

• 2016 runner up: Operation Pharmacist: Ending the Highs and Lows of Diabetes, St George’s University Hospitals NHS Foundation Trust (PDF, 637KB)

• 2015 winner: innovative use of ward glucose systems to reduce inpatient hypoglycaemia, Ipswich Hospital NHS Trust (Word, 26KB)

• 2014 winner: insulin prescription chart, Nottingham University Hospitals NHS Trust (PDF, 1MB)

• 2014 runner up: insulin prescription chart, East Sussex Healthcare NHS Trust (PDF, 730KB)

  East Sussex Healthcare NHS Trust also produced the following specific charts:East Sussex Healthcare NHS Trust also produced the following specific charts:
  • IV insulin DKA and HHS chart (PDF, 127KB)
  • IV insulin ACS chart (PDF, 126KB)
  • IV insulin surgey NBM chart (PDF, 126KB)

About JBDS-IP

The Joint British Diabetes Societies for Inpatient Care (JBDS-IP) was created in 2008 to ‘deliver a set of diabetes inpatient guidelines and propose standards of care within secondary care organisations’. JBDS-IP is supported by Diabetes UK, the Association of British Clinical Diabetologists (ABCD) and the Diabetes Inpatient Specialist Nurse (DISN) UK Group. JDBS-IP also work with NHS England, TREND-UK and other professional organisations. 

JBDS-IP consists of a number members and all four nations are represented. Members meet face-to-face twice a year and also connect via regular teleconferences. 

Chair 

Professor Ketan Dhatariya, Norfolk and Norwich University Hospitals NHS Foundation Trust

JBDS-IP Group

• Dr Ahmed Al-Sharefi, South Tyneside and Sunderland NHS Foundation Trust
• Dr Belinda Allan, Hull and East Yorkshire Hospital NHS Trust
• Dr Parizad Avari, Imperial College Healthcare NHS Trust
• Olivia Burr, Diabetes UK
• Elizabeth Camfield, Guy’s and St Thomas’ NHS Foundation Trust
• Erwin Castro, (East Sussex), Chair, Diabetes Inpatient Specialist Nurse UK Group
• Dr Jason Cheung, Norfolk and Norwich University Hospitals NHS Foundation Trust
• Dr Umesh Dashora, East Sussex Healthcare NHS Trust
• Dr Parijat De, Sandwell and West Birmingham Hospitals NHS Trust
• Professor Ketan Dhatariya, (Norwich), Chair, Joint British Diabetes Societies (JBDS) for Inpatient Care
• Dr Daniel Flanagan, Plymouth Hospitals NHS Trust
• Dr Stella George, East and North Hertfordshire NHS Trust
• Dr Chris Harrold, University Hospitals Coventry and Warwickshire NHS Trust
• Dr Masud Haq, Maidstone and Tunbridge Wells NHS Trust
• Dr Kath Higgins, University Hospitals of Leicester NHS Trust
• David Jones, Diabetes UK
• Andrea Lake, Cambridge University Hospitals NHS Foundation Trust
• Dr Anthony Lewis, Belfast Health and Social Care Trust, Northern Ireland
• Dr Sue Manley, University Hospitals Birmingham NHS Foundation Trust
• Flora Mates, Diabetes UK
• Dr Omar Mustafa, King’s College Hospital NHS Foundation Trust, London
• Philip Newland-Jones, University Hospital Southampton NHS Foundation Trust
• Dr Dipesh Patel, Royal Free London, NHS Foundation Trust
• Professor Gerry Rayman, Ipswich Hospitals NHS Trust
• Dr Stuart Ritchie, NHS Lothian
• Dr Aled Roberts, Cardiff and Vale University Health Board
• Professor Mike Sampson, Norfolk and Norwich University Hospitals NHS Foundation Trust
• Professor Alan Sinclair, Director Diabetes Frail Ltd
• Esther Walden, Diabetes UK
• Dr Peter Winocour, East and North Hertfordshire NHS Trust

For more information on JBDS-IP contact Christine Jones, Norfolk and Norwich University Hospitals NHS Foundation Trust, at christine.jones@nnuh.nhs.uk.

2012 JDBS-IP survey

A SurveyMonkey of JBDS-IP guidelines undertaken at the end of 2012 revealed:

• Guidelines have been actively distributed (>21,000 copies, excluding downloads)
• Between 85% and 100% of responding teams were aware of the guidelines
• Over 90% adoption in 118 UK Trusts for older guidelines, and around 50 per cent for 2012 guidelines
• Guidelines were rated highly in terms of patient safety, overall quality and clinical value.